logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jeffrey V. Lazarus

Graduate School of Public Health and Health Policy

75H指数
622论文数
7.6W被引数
收录论文 262
发表时间
logo
Changing epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policy欧洲肝细胞癌的流行病学和病因学变化：对临床实践和卫生政策的启示
errLancet Regional Health-Europe
IF13
err2026-09-03
err0
errOAAI
errBernhard Scheiner; Jeroen Dekervel; Fabio Piscaglia; Alessandro Vitale; Loreta Anesti Kondili; Bogdan Procopet; Jeffrey V. Lazarus; Maria Buti; Shira Zelber-Sagi; Matthias Pinter
err分享
err收藏
Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’回复‘弥合政策差距：将儿童纳入脂肪性肝病的全球议程’
errNature Reviews Gastroenterology & Hepatology
IF51
err2026-08-26
err0
PREAI
errJeffrey V. Lazarus; Bruno Halpern; Peter E. H. Schwarz; Veronica Miller; Ajay Duseja; Harriette G. C. Van Spall
err分享
err收藏
Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort StudySurveillance-detected Hepatocellular Carcinoma: A Nationwide Cohort Study 答：社会经济学不平等在治愈性治疗接受及生存方面的差异：一项全国性队列研究，针对通过监测发现的肝细胞癌
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2026-05-26
err0
errOAAI
errHannes Hagström; Jeffrey V. Lazarus; Malin Sternby Eilard; Adam Bergman; Magnus Rizell; Per Sandström; Juan Vaz
err分享
err收藏
Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in Europe实施循证酒精政策以减少酒精相关危害和肝脏疾病，促进欧洲公共卫生
errThe Lancet Regional Health - Europe
IF0
err2026-05-25
err0
errOAAI
errElisa Pose Méndez; Luis Antonio Díaz; Richard Parker; Mads Israelsen; Thomas Marjot; Ewan Forrest; Ashwin Dhanda; Catherine Paradis; Juan Pablo Arab; Aleksander Krag; Ramón Bataller; Frank Murray; Jeffrey V. Lazarus; Patrizia Carrieri; Paul N. Brennan
err分享
err收藏
Assessing Europe's policy readiness to confront the MASLD/MASH public health threat评估欧洲应对MASLD/MASH公共卫生威胁的政策准备情况
errThe Lancet Regional Health - Europe
IF0
err2026-05-25
err0
errOAAI
errJeffrey V. Lazarus; Trenton M. White; Leire Agirre-Garrido; Kushala W.M. Abeysekera; Paul N. Brennan; Radan Brůha; Stefan Buttigieg; Patrizia Carrieri; Helena Cortez-Pinto; Robert Flisiak; Sven M.A. Francque; Gema Frühbeck; Liliana Simona Gheorghe; Hannes Hagström; Adriaan G. Holleboom; Krasen Ivanov; Mojca Jensterle; Peter Jepsen; Juozas Kupčinskas; Henry E. Mark
err分享
err收藏
MASLD prevalence, incidence and global aspectsMASLD患病率、发病率及全球概况
errDiabetologia
IF10.2
err2026-05-21
err0
errOAAI
errSarah H. Wild; Jeffrey V. Lazarus; C. Wendy Spearman; Ponsiano Ocama; Josh Bilson; Xiao-Dong Zhou; Ming-Hua Zheng; Christopher D. Byrne
err分享
err收藏
Global position statement supporting a World Health Assembly resolution on steatotic liver disease支持世界卫生大会关于脂肪性肝病决议的全球立场声明
errNature Reviews Gastroenterology & Hepatology
IF51
err2026-04-15
err0
PREAI
errJeffrey V. Lazarus; Bruno Halpern; Peter E. H. Schwarz; Delfina Boudou; Harriette G. C. Van Spall; Veronica Miller; Ajay Duseja
err分享
err收藏
Excess mortality from cirrhosis by neighbourhood deprivation, aetiology, and clinical presentation: a Swedish register-based cohort study酒精性肝硬化死亡率的区域剥夺、病因学和临床表现的差异：一项基于瑞典登记数据的队列研究
errEClinicalMedicine
IF10
err2026-03-17
err0
errOAAI
errJuan Vaz; Jeffrey V. Lazarus; Hannes Hagström; Ulf Strömberg
err分享
err收藏
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease从病毒性肝炎检测中吸取的经验教训，为法律和政策应对脂肪性肝病提供信息
errNature Reviews Gastroenterology & Hepatology
IF51
err2026-01-30
err0
PREAI
errJeffrey V. Lazarus; Christopher J. Kopka; Aina Nicolàs; Safura Abdool Karim; Meena B. Bansal; Michael Betel; John F. Dillon; Pere Gines; Aleksander Krag; Veronica Miller; Cynthia A. Moylan; Alisa Pedrana; Paula Petrone; Jörn M. Schattenberg; Sunil S. Solomon; Norah Terrault; Ellie Dow; Maja Thiele
err分享
err收藏
Name MASLD/MASH — and act on it命名MASLD/MASH——并采取行动
errAnnals of Hepatology
IF4.4
err2026-01-12
err0
errOAAI
errJeffrey V. Lazarus; Mário G. Pessoa; Debbie L. Shawcross; Peter Schwarz; Grace L. Su; Simon Barquera
err分享
err收藏
Name MASLD/MASH — and act on it命名MASLD/MASH——并采取行动
errJHEP Reports
IF7.5
err2026-01-12
err0
errOAAI
errJeffrey V. Lazarus; Mário G. Pessoa; Debbie L. Shawcross; Peter Schwarz; Grace L. Su; Simon Barquera
err分享
err收藏
Name MASLD/MASH — and act on it命名MASLD/MASH-并采取行动
errHepatology Communications
IF4.6
err2026-01-09
err0
errOAAI
errLazarus, Jeffrey V.; Pessoa, Mário G.; Shawcross, Debbie L.; Schwarz, Peter; Su, Grace L.; Barquera, Simon
err分享
err收藏
Estimated cost-savings from integrated care for HIV, diabetes and hypertension in sub-Saharan Africa: a cost-minimisation analysis撒哈拉以南非洲地区针对艾滋病、糖尿病和高血压的整合护理的预估成本节约：一项成本最小化分析
errGlobal Health Action
IF2.6
err2025-12-31
err0
PREAI
errJaoude, Gerard Joseph Abou; Kivuyo, Sokoine; Birungi, Josephine; Okebe, Joseph; Ramaiya, Kaushik; Namakoola, Ivan; Ouma, Simple; Garrib, Anupam; van Widenfelt, Erik; Lazarus, Jeffrey Victor; Mutungi, Gerald; Ubuguyu, Omary; Ssali, Mina Nakawuka; Sewankambo, Nelson K.; Skordis, Jolene; Mfinanga, Sayoki; Nyirenda, Moffat J.; Jaffar, Shabbar; Batura, Neha
err分享
err收藏
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study代谢功能障碍相关的脂肪性肝病和代谢功能障碍相关的脂肪性肝炎的最佳购买: 全球Delphi研究
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2025-12-13
err0
PREAI
errJeffrey V Lazarus; Leire Agirre-Garrido; Trenton M White; Anish K Arora; Melina I Manolas; Luis Antonio Diaz; Juan Pablo Arab; Shira Zelber-Sagi; Naim Alkhouri; C Wendy Spearman; Jörn M Schattenberg; Loreta A Kondili; Patrizia Carrieri; Holly F Lofton; Priya Jaisinghani; Sonal Kumar; Ajay Duseja; Mohamed El-Kassas; Hirokazu Takahasi; Debbie L Shawcross
err分享
err收藏
Longitudinal Risk of Cirrhosis by Steatotic Liver Disease Subtype Among 1.5 Million Individuals in the U.S.美国150万个体中，按脂肪性肝病亚型划分的肝硬化纵向风险
errJHEP Reports
IF7.5
err2025-11-15
err0
errOAAI
errMai Sedki; Zeyuan Yang; Ashwani K. Singal; Mário Guimarães Pessoa; Aleksander Krag; Jörn M. Schattenberg; Linda Henry; Saleh Alqahtani; Jeffrey V. Lazarus; Zobair M. Younossi; Robert J. Wong
err分享
err收藏
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries六国中所有糖尿病患者代谢功能障碍相关脂肪性肝病筛查的成本
errLiver International
IF5.2
err2025-11-05
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
err分享
err收藏
Featured Cover精选封面
errLiver International
IF5.2
err2025-10-30
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
err分享
err收藏
Cirrhosis incidence across socioeconomic and demographic groups in Sweden: a register-based cohort study瑞典不同社会经济和人口群体中肝硬化的发病率：一项基于登记的队列研究
errThe Lancet Public Health
IF25.2
err2025-10-27
err0
errOAAI
errJuan Vaz; Jeffrey V Lazarus; Ulf Strömberg; Hannes Hagström
err分享
err收藏
Announcing The Lancet Regional Health – Europe Series on ending the chronic liver disease public health threat in Europe宣布《柳叶刀·区域健康—欧洲》系列发布，主题为终结欧洲慢性肝病公共卫生威胁。
errThe Lancet Regional Health - Europe
IF0
err2025-10-11
err0
errOAAI
errJeffrey V. Lazarus; Camila A. Picchio; Elisa Pose; Ivana Nedic; Paul Brennan
err分享
err收藏
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries代谢功能障碍相关脂肪性肝炎（MASH）的全球临床、人文和经济影响预测项目补充资料：基于九国数据的无所作为的成本
errClinical Gastroenterology and Hepatology
IF12
err2025-09-08
err0
PREAI
errZobair M. Younossi; James M. Paik; Jeffrey V. Lazarus; Patrizia Burra; Yuichiro Eguchi; Frank Tacke; Javier Crespo; Cristiane A. Villela-Nogueira; Paul N. Brennan; Hussain Abdulrahman Al-Omar; Manuel Romero-Gomez; Cyrielle Caussy; Mário Guimarães Pessoa; Kenneth Cusi; Michael Roden; Hirokazu Takahashi; Amalia Gastaldelli; Jörn M. Schattenberg; Claudia Pinto Oliveira; Takumi Kawaguchi; Yuko Eguchi; Jerome Boursier; Faisal Abaalkhail; Jeremy W. Tomlinson; Alina M. Allen; Vincent Wai-Sun Wong; Elisabetta Bugianesi; Philip N. Newsome; Jose Luis Calleja; Nicolai Brachowicz; Leire Agirre-Garrido; Douglas Maya-Miles; Habeeb I.A. Razack; Henry E. Mark; Ariana Nader; Sara Battistella; Jennifer Margier; Alessandra Risso; Maria Stepanova; Fatema Nader; Linda Henry; Laurent Castera; Saleh A. Alqahtani
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
D
Dan J. Stein
H 指数: 249 · 论文数: 4.2K
C
Cyrus Cooper
H 指数: 236 · 论文数: 3.2K
S
Simon I Hay
H 指数: 231 · 论文数: 900
A
Ali H. Mokdad
H 指数: 215 · 论文数: 933
H
Hermann Brenner
H 指数: 202 · 论文数: 3.3K
查看更多